Professor Sam Denmeade, from Johns Hopkins University School of Medicine in Baltimore, US, who led the study, said: ""Our goal is to shock the cancer cells by exposing them rapidly to very high followed by very low levels of testosterone in the blood. The results are unexpected and exciting